{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T11:18:09Z","timestamp":1777807089458,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMC"],"published-print":{"date-parts":[[2016,8,30]]},"DOI":"10.2174\/0929867323666160812151054","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T10:05:24Z","timestamp":1473069924000},"page":"2692-2705","source":"Crossref","is-referenced-by-count":14,"title":["The Role of Nitric Oxide Synthase Inhibitors in Schizophrenia"],"prefix":"10.2174","volume":"23","author":[{"given":"Nikolaos","family":"Pitsikas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/144763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T10:05:20Z","timestamp":1473069920000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=0929-8673&volume=23&issue=24&spage=2692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":0,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2016,8,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867323666160812151054","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,30]]}}}